Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

ER - Notice: Half Year Results and Capital Markets Day

Company: Hipgnosis Songs Fund Limited Date: 2022-11-30 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 National Storage Mechanism | Additional information ![](https://tracker.live.rns-distribution.com/track.live-rns/4595310_abef74e1e81917cf8d441a20d8c6f0ac.png)

RNS Number : 9993H

Hipgnosis Songs Fund Limited

30 November 2022

LEI: 213800XJIPNDVKXMOC11

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Notice of Half-Year Results and Capital Markets Day

30 November 2022

The Board of Hipgnosis Songs Fund Limited, the first UK listed investment company offering investors a pure-play exposure to songs and associated intellectual property rights, and its Investment Adviser, Hipgnosis Song Management Limited, will announce its Half-Year Results for the six months to 30 September 2022, on 8 December 2022.

In addition, it will also host a Results Presentation and Capital Markets Day starting at 10:30am GMT on Thursday 8 December 2022, in the Maxwell Library, IET London: Savoy Place, 2 Savoy Place, London, WC2R 0BL.

Registration for the event in person is available at:

[mailto:kelly.poynter@singercm.com?subject=Hipgnosis%20CMD%20|%20I%20would%20like%20to%20attend%20in%20person](mailto:kelly.poynter@singercm.com?subject=Hipgnosis%20CMD%20|%20I%20would%20like%20to%20attend%20in%20person)

Registration for the live webcast is available at:

[https://www.lsegissuerservices.com/spark/HipgnosisSongsFundLtd/events/522395c4-b376-45c8-a2c4-d1701fc2447c](https://www.lsegissuerservices.com/spark/HipgnosisSongsFundLtd/events/522395c4-b376-45c8-a2c4-d1701fc2447c)

A video recording of the event will be made available on the Company's website at [www.hipgnosissongs.com](http://www.hipgnosissongs.com/ "http://www.hipgnosissongs.com/") after the event. Please note if you are joining via the live stream, you will not be able to ask questions.

These presentations will not contain any material new financial or trading information.

|     |     |
| --- | --- |
| For further information please contact:<br><br>Hipgnosis Song Management<br><br>Merck Mercuriadis<br><br>Chris Helm<br><br>Giles Croot (Media)<br><br>Rufina Pavry (Investors) | +44 (0)20 4542 1511<br><br>+44 (0)20 4542 1530 |
| Singer Capital Markets - Joint Corporate Broker<br><br>James Moat / James Maxwell / Alex Emslie (Corporate Finance)<br><br>Alan Geeves / James Waterlow / Sam Greatrex (Sales) | +44 (0)20 7496 3000 |
| J.P. Morgan Cazenove - Joint Corporate Broker<br><br>William Simmonds / Jérémie Birnbaum (Corporate Finance)<br><br>James Bouverat (Sales) | +44 (0)20 7742 4000 |
| RBC Capital Markets - Joint Corporate Broker<br><br>Elliot Thomas / Max Avison (Corporate Finance)<br><br>Lisa Tugwell / Anastasia Mikhailova (Sales) | +44 (0)20 7635 4000 |
| Ocorian \- Company Secretary & Administrator<br><br>Lorna Zimny | +44 (0) 28 9693 0222 |
| The Outside Organisation<br><br>Alan Edwards / Nick Caley | +44 (0)7711 081 843 |
| FTI Consulting<br><br>Neil Doyle / Paul Harris / Laura Ewart | +44 (0)7771 978220; +44 (0)7809 411882; +44 (0)7761 332646 |
| All US music publicity enquiries<br><br>Fran Defeo | +1 917 767 5255 |

  

  

Notes to Editors

About Hipgnosis Songs Fund

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. The Company has raised a total of almost £1.3 billion (gross equity capital) through its Initial Public Offering on 11 July 2018, and subsequent issues in April 2019, August 2019, October 2019, July 2020, September 2020, February 2021 and July 2021. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premium segment of the Main Market, and in March 2020 became a constituent of the FTSE 250 Index. Since April 2021, the Company has been resident in the UK for tax purposes and is recognised as an investment trust under applicable HMRC regulations.

About Hipgnosis Song Management Limited

The Hipgnosis Songs Fund's Investment Adviser is Hipgnosis Song Management Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of Hipgnosis Song Management Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, David A. Stewart, Poo Bear, Bill Leibowitz, Ian Montone and Rodney Jerkins.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [rns@lseg.com](mailto:rns@lseg.com) or visit [www.rns.com](http://www.rns.com/).  

  

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our [Privacy Policy](https://www.lseg.com/privacy-and-cookie-policy).

END

NOREAEFNAFAAFAA